Martha J. Demski, Director at ADMA BIOLOGICS, INC. (ADMA), bought 2,000 shares at $2.88 ($6K) on 2020-08-13, disclosed to the SEC on 2020-08-14.
Open-market purchase of $6k ADMA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CMRX | BUY | 2022-05-17 | $16K | — | Filing → |
| ADMS | SELL | 2021-06-08 | $10K | — | Filing → |
| ADMA | BUY | 2020-09-14 | $5K | — | Filing → |